Fecal Molecular Susceptibility-guided Hp First-line Therapy

Clinical trial NCT07405684 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07405684
Sponsor: Shanghai Zhongshan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

HELICOBACTER PYLORI INFECTIONS

Start date: 2026-02-28
Primary completion: 2027-12-31
Enrollment: 544

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.